BillionToOne, Inc.
BLLN · XNASCIK 2070849fmd_04N59GYQTDQ4B801CFFSH3QXZ4Services · Services-Medical LaboratoriesTemplate: Standard
Coverage: Jan 01, 2023 to Sep 30, 2026, 10 periods
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total revenues | 72 | 153 | 305 |
| Cost of revenue | 54 | 72 | 97 |
| Gross profit | 17 | 81 | 208 |
| Research and development | 22 | 37 | 49 |
| Selling, general and administrative | 64 | 91 | 143 |
| Total operating expenses | 87 | 128 | 192 |
| Operating income | (69) | (47) | 16 |
| Interest expense | 3 | 2 | 0 |
| Interest and investment income | 3 | 6 | 8 |
| Other non-operating income (expense) | (13) | 6 | (8) |
| Income before taxes | (83) | (42) | 8 |
| Income tax expense | 0 | 0 | 0 |
| Net income from continuing operations | (83) | (42) | 7 |
| Net income | (83) | (42) | 7 |
| Net income to common shareholders | (83) | (42) | 3 |